Bill Text: MI SB1113 | 2015-2016 | 98th Legislature | Introduced
Bill Title: Health; screening; requirement for use of certain standardized hereditary breast and ovarian cancer screening questions by physicians; provide for. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding secs. 17019 & 17519.
Spectrum: Partisan Bill (Republican 4-0)
Status: (Introduced - Dead) 2016-10-18 - Referred To Committee On Health Policy [SB1113 Detail]
Download: Michigan-2015-SB1113-Introduced.html
SENATE BILL No. 1113
October 18, 2016, Introduced by Senators SCHUITMAKER, O'BRIEN, PROOS and MARLEAU and referred to the Committee on Health Policy.
A bill to amend 1978 PA 368, entitled
"Public health code,"
(MCL 333.1101 to 333.25211) by adding sections 17019 and 17519.
THE PEOPLE OF THE STATE OF MICHIGAN ENACT:
Sec. 17019. (1) Beginning January 1, 2018, a physician who
specializes in primary care shall include on the physician's
patient intake form questions that are endorsed by the United
States Preventative Service Task Force or the National
Comprehensive Cancer Network and are designed to identify a patient
who has a family history that may be associated with an increased
risk of hereditary breast or ovarian cancer.
(2) If a patient's response to 1 or more of the questions
described in subsection (1) indicates a family history that may be
associated with an increased risk of hereditary breast or ovarian
cancer, the physician shall provide the patient with information on
genetic counseling for the purpose of determining whether genetic
testing for mutations in genes associated with breast and ovarian
cancer is appropriate for the patient.
Sec. 17519. (1) Beginning January 1, 2018, a physician who
specializes in primary care shall include on the physician's
patient intake form questions that are endorsed by the United
States Preventative Service Task Force or the National
Comprehensive Cancer Network and are designed to identify a patient
who has a family history that may be associated with an increased
risk of hereditary breast or ovarian cancer.
(2) If a patient's response to 1 or more of the questions
described in subsection (1) indicates a family history that may be
associated with an increased risk of hereditary breast or ovarian
cancer, the physician shall provide the patient with information on
genetic counseling for the purpose of determining whether genetic
testing for mutations in genes associated with breast and ovarian
cancer is appropriate for the patient.
Enacting section 1. This amendatory act takes effect 90 days
after the date it is enacted into law.
